First transgenic primate model created for hepatitis B research
Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...
New Atlas11d
Preventing immune system burnout when fighting chronic illness & cancer
Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...
The American Journal of Managed Care14d
New AGA Guidelines Recommend Risk-Based Prophylaxis for Hepatitis B Reactivation Monitoring
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B reactivation (HBVr) in at-risk individuals, recommending antiviral prophylaxis for ...
News Medical20d
Updated guidelines for preventing and managing hepatitis B virus reactivation
Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation ... particularly B-cell depleting agents like rituximab, or disease. HBsAg-positivity ...
Taiwan News3d
Taiwan study reveals link between hepatitis B, fatty liver disease, and mortality rate
TAIPEI (Taiwan News) — A study conducted by National Taiwan University Hospital has uncovered a link between hepatitis B, ...
precisionmedicineonline3d
FDA Clears Lion TCR to Begin Phase II Trial of TCR T-Cell Therapy in HBV-Related Liver Cancer
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Vietnam Investment Review on MSN4d
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...